IL2 and tuberculosis: When the gross TB pathology or lesions was evaluated in details and compared between groups using the scoring system as we and others previously described [20], [21], [22], we found that the Picostim/IL2-treated group exhibited significantly milder TB lesions or pathology than saline/BSA-treated and IL2-treated control groups(Fig. 3a).